Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 9/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 6/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 7/20 | 0.64 |
| ▸ | PDE4A | P27815 | 4/20 | 0.64 |
| ▸ | PDE4B | Q07343 | 4/20 | 0.64 |
| ▸ | PDE4C | Q08493 | 4/20 | 0.64 |
| ▸ | PDE4D | Q08499 | 4/20 | 0.64 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.51 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.50 |
| ▸ | ALPL | P05186 | 1/20 | 0.50 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1-Methylxanthine SCHEMBL27529726 | 0.98 | ADORA2B (0.96) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| 1-Methylxanthine SCHEMBL28309011 | 0.98 | ADORA2B (0.96) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| 1-Methylxanthine SCHEMBL9682658 | 0.98 | ADORA2B (0.96) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| 1-Methylxanthine SCHEMBL28460409 | 0.92 | ADORA2B (0.84) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| 1-Methylxanthine SCHEMBL16859909 | 0.89 | ADORA2B (0.79) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| 1-Methylxanthine SCHEMBL29001829 | 0.89 | ADORA2B (0.79) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| Theophylline Anhydrous SCHEMBL1128138 | 0.88 | ADORA2A (0.77) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| 1-Methylxanthine SCHEMBL7270651 | 0.88 | ADORA2B (0.77) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| 3-Methylxanthine SCHEMBL1892894 | 0.88 | ADORA2B (0.77) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| 1-Methylxanthine SCHEMBL27663813 | 0.88 | ADORA2B (0.77) | ADORA2BADORA2AADORA3PDE4APDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 16622 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4728052-A1 | SYSTEMS AND METHODS OF CELL TRANSPORT AT AMBIENT TEMPERATURE | Bedford Research Foundation (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4363043-B1 | COMPOSITIONS FOR USE IN METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2026-04-22 | — | — | EP | claimed |
| EP-4719373-A1 | PHOTODYNAMIC THERAPY COMBINATIONS FOR IMPROVEMENT OF ACTINIC KERATOSIS, ACNE AND BASAL CELL CARCINOMA | Alexandroff, Anton (GB) | 2026-04-08 | — | — | EP | claimed |
| US-12594421-B2 | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields | NOVOCURE GMBH (CH) | 2026-04-07 | — | — | US | claimed |
| EP-3521419-B1 | METHOD FOR PRODUCING BROWN ADIPOCYTES AND COMPOSITION | KYOTO PREFECTURAL PUBLIC UNIV CORP (JP) | 2026-03-18 | — | — | EP | claimed |
| US-20260060970-A1 | Use of a Therapeutic Agent with Phosphodiesterase-7 Inhibitory Activity for the Treatment and Prevention of Diseases Associated with Chronic Fatigue, Exhaustion and/or Exertional Intolerance | MITODICURE GMBH (DE) | 2026-03-05 | — | — | US | claimed |
| US-20260062414-A1 | NOVEL COCRYSTALS OF METHYLXANTHINES, THEIR POLYMORPHS AND PROCESS THEREOF | FERTIS INDIA PVT LTD (IN) | 2026-03-05 | — | — | US | claimed |
| US-20260060949-A1 | METHOD FOR TREATING DAMAGE INDUCED BY SLEEP DEPRIVATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-03-05 | — | — | US | claimed |
| EP-4696298-A2 | PERSONAL CLEANSING COMPOSITION | Byrne, Daniel (IE) | 2026-02-18 | — | — | EP | claimed |
| EP-0167566-A1 | ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING XANTHINES AND METHODS OF USING SAME | SUNSHINE, Abraham (US) | 1986-01-15 | — | — | EP | claimed |
| US-4562194-A | BENZOPHENONE COMPOUND IN COMBINATION WITH 3-ISOBUTYL-1-METHYLANTHINE | WARNER-LAMBERT COMPANY (US) | 1985-12-31 | — | — | US | claimed |
| EP-0165308-A1 | ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING XANTHINES AND METHODS OF USING SAME. | RICHARDSON VICKS INC (US) | 1985-12-27 | — | — | EP | claimed |
| US-4558051-A | Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same | RICHARDSON-VICKS, INC. (US) | 1985-12-10 | — | — | US | claimed |
| WO-1985002540-A1 | ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING XANTHINES AND METHODS OF USING SAME | RICHARDSON-VICKS, INC. (US) | 1985-06-20 | — | — | WO | claimed |
| WO-1985002542-A1 | ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING XANTHINES AND METHODS OF USING SAME | SUNSHINE ABRAHAM | 1985-06-20 | — | — | WO | claimed |
| US-4390532-A | MUCOPOLYSACCHARIDES, SHIN DISORDERS | DR. CARL HAHN, G.M.B.H. (DE) | 1983-06-28 | — | — | US | claimed |
| US-4364922-A | ATRIOVENTRICULAR CONDUCTION BLOCK | UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) | 1982-12-21 | — | — | US | claimed |
| US-4273774-A | 1,3-DIMETHYL-5-AMINOADMANTANE TOGETHER WITH CAFFEINE OR THEOPHYLLINE | MERZ & CO. (DE) | 1981-06-16 | — | — | US | claimed |
| US-4262089-A | REAGENTS FOR IMMUNOASSAY | SYVA COMPANY (US) | 1981-04-14 | — | — | US | claimed |